Stay updated on IMM60 and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.

Latest updates to the IMM60 and Pembrolizumab Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.5.4 is added to the record history, and the previous v3.5.3 entry is removed. This indicates a small backend update to the page's revision history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new latest revision, v3.5.3, is added to the revision history, replacing the previous v3.5.2; this updates the page's version metadata without altering the study information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history shows Revision: v3.5.2 replacing Revision: v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedVersion 10 adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, IPDSharing, and Document Section to the record, and includes a QC note 'Quality Control Review Has Not Concluded' with a Returned entry dated 2026-03-24.SummaryDifference1%

- Check59 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was removed from the history.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a 'Results Submitted' entry in the Record History and updated the version to v3.4.3. The previous 'No Results Posted' entry was removed.SummaryDifference0.2%

Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.